EUVIMEDEUVIMED entdecken
Crossref

Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity

Michael A Pfaller, Cecilia G Carvalhaes iD, Mariana Castanheira iD

Mycoses · 2023

DOI: 10.1111/myc.13620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2023. Verfasst von Michael A Pfaller und 2 weiteren Autor:innen. Beteiligte Einrichtung: JMI Laboratories, North Liberty, Iowa, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Itraconazole. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We evaluated the activity of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin against 1468 invasive moulds collected worldwide from 2018 to 2021. Most (>92%) of the Aspergillus spp. isolates were wildtype (WT) to amphotericin B, caspofungin and the azoles. Azole–non‐wildtype A. fumigatus rates were higher in Europe (9.5%) and North America (9.1%) than Latin America (0.0%; only 12 isolates) and the Asia‐Pacific region (5.3%). Amphotericin B and caspofungin were active against azole–non‐wildtype A. fumigatus isolates. Posaconazole and amphotericin B were the most active agents against the Mucorales. Among the less common moulds, several expressed a pan‐azole–resistant phenotype; many of these species also showed elevated MIC values (MIC, >2 mg/L) for amphotericin B and caspofungin. Although most isolates of Aspergillus spp. remain WT to the azoles, azole resistance is increasing in both North America and Europe. Amphotericin B and caspofungin exhibit potentially useful activity against azole‐resistant A. fumigatus .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsItraconazoleVoriconazoleAmphotericin BCaspofunginMicrobial Sensitivity TestsFungiAspergillusAzolesDrug Resistance, FungalTriazoles

Stichwörter der Autor:innen

antifungal activityazolesfilamentous fungi

Substanzen

Antifungal AgentsVoriconazoleItraconazoleAmphotericin BCaspofunginAzolesposaconazoleTriazoles

Autor:innen und Institutionen

  • JMI Laboratories, North Liberty, Iowa, USA.
  • University of Iowa College of Medicine, Iowa City, Iowa, USA.

ORCID-Profile: Cecilia G Carvalhaes, Mariana Castanheira

Förderung

  • Gilead Sciences

Zitieren

APA

Pfaller, M. A., Carvalhaes, C. G., & Castanheira, M. (2023). Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity. Mycoses. https://doi.org/10.1111/myc.13620

Vancouver

Pfaller MA, Carvalhaes CG, Castanheira M. Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity. Mycoses. 2023. doi:10.1111/myc.13620

BibTeX
@article{Pfaller2023,
  author = {Pfaller, Michael A and Carvalhaes, Cecilia G and Castanheira, Mariana},
  title = {Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity},
  journal = {Mycoses},
  year = {2023},
  doi = {10.1111/myc.13620}
}
Kostenlos starten →